Application
Figure 1: Western blot analysis using CHK2 mouse mAb against cell lysate from various cell types.Application
Figure 2: Immunohistochemical analysis of paraffin-embedded human lung carcinoma (A), liver carcinoma (B), breast carcinoma (C) and kiney carcinoma (D), showing nuclear localization with DAB staining using CHK2 mouse mAb.Application
Figure 3: Confocal immunofluorescence analysis of Hela cells using CHK2 mouse mAb (green), showing nuclear localization. Red: Actin filaments have been labeled with DY-554 phalloidin.| Product Name | CHK2 |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | CDS1; LFS2; CHEK2 |
| Immunogen | Purified recombinant fragment of human CHK2 (aa481-531) expressed in E. Coli. |
| Clonality | Monoclonal |
|---|---|
| Host Species | Unknow |
| Tested Applications | WBIHCICCICC/IF |
| WB:1:250~1:1000 IHC:1:20~1:100 ICC:1:100~1:200 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|
| Species Reactivity | Human |
| Alternative Names | CDS1 LFS2 CHEK2 |
|---|---|
| Molecular Weight(MW) | 61kDa |
| Entrez Gene | 11200 |
|---|
Application
Figure 1: Western blot analysis using CHK2 mouse mAb against cell lysate from various cell types.
Application
Figure 2: Immunohistochemical analysis of paraffin-embedded human lung carcinoma (A), liver carcinoma (B), breast carcinoma (C) and kiney carcinoma (D), showing nuclear localization with DAB staining using CHK2 mouse mAb.
Application
Figure 3: Confocal immunofluorescence analysis of Hela cells using CHK2 mouse mAb (green), showing nuclear localization. Red: Actin filaments have been labeled with DY-554 phalloidin.| Application Notes | WB:1:250~1:1000 IHC:1:20~1:100 ICC:1:100~1:200 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|---|
| Form | Ascitic fluid containing 0.03% sodium azide. |
|---|---|
| Storage Instructions | 4℃; -20℃ for long term storage |
